Novartis AG (LTS:0K9E)
$ 104.615 -1.015 (-0.96%) Market Cap: 209.73 Bil Enterprise Value: 227.87 Bil PE Ratio: 12.44 PB Ratio: 5.03 GF Score: 80/100

Novartis AG PSMAfore Data at ESMO Presentation Transcript

Oct 24, 2023 / 11:00AM GMT
Release Date Price: $95.17 (+0.30%)

Oct 24, 2023 / 11:00AM GMT
Presentation
Oct 24, 2023 / 11:00AM GMT

=====================
Corporate Participants
=====================
* Jeff Legos
Novartis AG - Senior VP & Global Program Head of Oncology
* Samir Shah
Novartis AG - Global Head of IR
* Shreeram Aradhye
Novartis AG - President of Global Drug Development & Chief Medical Officer

=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Gary Steventon
BNP Paribas Exane, Research Division - Research Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* Mark Douglas Purcell
Morgan Stanley, Research Division - Equity Analyst
* Michael Thomas Nedelcovych
TD Cowen, Research Division - Research Associate
* Peter James Welford
Jefferies LLC, Research Division - Senior Equity Analyst & European Pharmaceuticals Analyst
*

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot